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Abstract
Background—The alcohol deprivation effect (ADE) is characterized by transient excessive
alcohol consumption upon reinstatement of ethanol following a period of ethanol deprivation.
While this phenomenon has been observed in rats using both bottle drinking (consummatory
behavior) and operant self-administration (consummatory and appetitive “ethanol-seeking”
behavior) procedures, ADE studies in mice have primarily relied on bottle drinking measures.
Furthermore, the neurochemical pathways that modulate the ADE are not well understood.
Therefore, we determined whether the ADE can be observed in C57BL/6J mice using operant self-
administration procedures and if expression of the ADE is modulated by the corticotropin
releasing factor-1 (CRF-1) receptor.
Methods—C57BL/6J mice were trained in a 2-hour operant self-administration paradigm to
lever press for 10% ethanol or water on separate response keys. Between operant sessions, mice
had access to ethanol in their homecage. Once stable responding occurred, mice were deprived of
ethanol for 4-days, and were then retested with ethanol in the operant paradigm for 3 consecutive
days. Next, to assess the role of the CRF-1 receptor, mice were given intraperitoneal (i.p.)
injection (0, 10, or 20 mg/kg) of the CRF-1 receptor antagonist CP-154,526 30-minutes before
ADE testing. Additional experiments assessed 1) ADE responding in which the alternate response
lever was inactive, 2) the effects of CP-154,526 on self-administration of a 1% sucrose solution
following 4-days of deprivation, and 3) ADE responding in which mice did not received i.p.
injections throughout the experiment.
Results—Mice exhibited a significant increase in post-deprivation lever responding for ethanol
with either a water reinforced or inactive alternate lever. Interestingly, i.p. injection of a 10 mg/kg
dose of CP-154,526 protected against the ADE while not affecting lever responding for a sucrose
solution. Finally, baseline and deprivation-induced increases of ethanol reinforced lever
responding were greater in mice not given i.p. injections.
Conclusions—The ADE in C57BL/6J mice can be modeled using the operant self-
administration paradigm and increased ethanol self-administration associated with the ADE is
modulated by CRF-1 receptor signaling.
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INTRODUCTION
Alcohol relapse is a major problem in the treatment of alcoholism. Approximately 60–80%
of abstinent alcoholics will relapse at one point in their lifetime (Barrick and Connors, 2002;
Chiauzzi, 1991). Thus, understanding the neurobiology of relapse and associated behaviors
is a critical step towards the development of drugs aimed at treating alcoholism. Relapse
after long periods of abstinence is frequently associated with excessive, or uncontrolled,
ethanol drinking (Holter et al., 2000). Recent procedures have been developed and validated
as animal models of this uncontrolled ethanol drinking. One procedure involves periodic
deprivation from ethanol after which animals consume significantly more ethanol than they
had consumed prior to the deprivation period. This phenomenon has been labeled the
alcohol deprivation effect (ADE) and is thought to model compulsive uncontrolled relapse
drinking characteristic of alcohol dependent humans (Spanagel and Holter, 1999).
The ADE is a robust phenomenon evident in rats (Backstrom et al., 2004b; Bell et al., 2004;
Colombo et al., 2003; Dayas et al., 2004; Fullgrabe et al., 2007; Funk et al., 2004; Heyser et
al., 1997; Holter et al., 2000; McKinzie et al., 1998; Oster et al., 2006; Rodd-Henricks et al.,
2001; Rodd-Henricks et al., 2000a; Rodd-Henricks et al., 2000b; Rodd et al., 2003; Rodd et
al., 2006; Serra et al., 2003; Vengeliene et al., 2005; Vengeliene et al., 2006; Wolffgramm
and Heyne, 1995), mice (Cowen et al., 2003a; Cowen et al., 2003b; Khisti et al., 2006;
Melendez et al., 2006; Sanchis-Segura et al., 2006; Zghoul et al., 2007), monkeys (Kornet et
al., 1990; Sinclair, 1971) and humans (Burish et al., 1981; Mello, 1972). The ADE can be
seen at ethanol deprivation intervals as short as 12-hours (Sinclair et al., 1989) or as long as
75-days (Sinclair, 1973), and has been shown to increase in magnitude and duration
following multiple cycles of ethanol deprivation in alcohol preferring (P) rats and high
alcohol drinking (HAD) rats (Breese et al., 2004; McKinzie et al., 1998; Rodd-Henricks et
al., 2001; 2002a; b; Rodd et al., 2003). Importantly, ADE ethanol drinking appears to be
truly “uncontrolled” as rats will continue to drink increased amounts of ethanol that are
adulterated with aversive tastes such as quinine (Spanagel et al., 1996).
Ingestive behavior (i.e., feeding and drinking) is complex and may be divided into at least
two components. Appetitive behaviors are those used to locate and acquire stimuli (e.g.,
food and water) in the environment while consummatory behaviors are those used to directly
consume the stimuli once they have been obtained (Samson and Hodge, 1995). Previous
experiments evaluating the ADE in mice have primarily measured consummatory behavior,
that is, the mice engaged in simple consumption of the ethanol solution from a sipper tube
that extended into the cage after a period of imposed ethanol abstinence. Operant procedures
allow for the analysis of consummatory behavior as well as appetitive or “seeking”
responses (i.e., lever pressing is required to gain access to the ethanol solution). The
distinction between appetitive and consummatory behavior has a useful clinical application.
Some human alcoholics report a subjective “craving” component toward alcohol (Jellinek,
1955) which may ultimately drive intentional behaviors involved in obtaining access to
alcohol (i.e., the appetitive component). Additionally, alcoholism is thought to entail loss of
control over ethanol drinking (Marlatt and George, 1984) once consumption has been
initiated (i.e., the consummatory component). Furthermore, drugs acting on dopamine or
glutamatergic receptors have been found to uniquely influence consummatory or appetitive
behaviors associated with ethanol ingestion (Czachowski et al., 2001a; Czachowski et al.,
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2001b; Czachowski et al., 2002). Because different neuronal pathways appear to modulate
appetitive versus consummatory behaviors during ethanol self-administration, and because
ADE studies in mice have relied on bottle drinking procedures, one goal of the present
project was to determine if a reliable ADE could be observed in C57BL/6J mice using
operant self-administration procedures.
A second goal of the present report was to further characterize the neurochemical substrate
involved in modulating the ADE. Previous studies utilizing pharmacological approaches
have implicated the dopamine D3 (Vengeliene et al., 2006), glutamate (Backstrom et al.,
2004a; Holter and Spanagel, 1999; Rodd et al., 2006; Sanchis-Segura et al., 2006; Spanagel
et al., 1996; Vengeliene et al., 2005)] and opioid (Holter et al., 2000) receptors in signaling
of ADE drinking. Another interesting target is corticotropin releasing factor (CRF), a 41
amino acid polypeptide with high concentrations in the hypothalamus, the brainstem, and
the amygdala (Swanson et al., 1983). Both acute and chronic ethanol exposure activate
central CRF pathways (Koob et al., 1993; Rasmussen et al., 2000; Rivier et al., 1984).
Increased levels of CRF are observed in the amygdala during ethanol withdrawal (Merlo
Pich et al., 1995) and the anxiogenic effect of ethanol withdrawal is reversed by CRF
receptor antagonists (Breese et al., 2004; Knapp et al., 2004; Overstreet et al., 2004;
Rassnick et al., 1993). Of critical interest, administration of CRF receptor antagonists have
been shown to attenuate excessive ethanol drinking in ethanol-dependent rodents without
influencing ethanol intake by non-dependent animals (Chu et al., 2007; Finn et al., 2007;
Funk and Koob, 2007; Funk et al., 2006; Funk et al., 2007; Gehlert et al., 2007; Overstreet et
al., 2007; Valdez et al., 2002). These observations suggest that central CRF receptor
signaling modulates increased ethanol drinking in dependent animals and thus make CRF a
possible candidate in the modulation of ADE drinking. To address this question, we studied
the expression of ADE behavior in C57BL/6J mice following administration of the CRF-1
receptor antagonist, CP-154,526. Data from the present report suggest that the ADE can be
modeled in C57BL/6J mice using an operant self-administration paradigm, and that
expression of the ADE is modulated by CRF-1 receptor signaling.
METHODS
Animals
Male C57BL/6J mice (Jackson Laboratory, Bar Harbor ME) were used in all experiments.
Mice were 6–8 weeks old and weighed between 25–30 g at the start of all experiments and
were single housed in polypropylene cages with corncob bedding and ad libitum access to
food and water. Standard rodent chow (Teklad, Madison, WI) and water were available at all
times except were noted. The vivarium rooms were maintained at an ambient temperature of
22° C with a 12-hour/12-hour light-dark cycle. All experimental procedures were approved
by the University of North Carolina Animal Care and Use Committee (IACUC) and
complied with the NIH Guide for Care and Use of Laboratory Animals (Council, 1996).
Drugs
CP-154,526 (butyl-[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-
yl]-ethylamine) was donated by Pfizer (Groton, CT), and was suspended in a vehicle of
0.5% carboxymethylcellulose (CMC). CP-154,526 displays high affinity for the CRF-1
receptor (Ki < 10 nM) and blocks CRF-stimulated adenylate cyclase activity in rodent
pituitary and cortical membranes (Lundkvist et al., 1996; Schulz et al., 1996). Peripheral
administration of CP-154,526 crosses the blood-brain barrier and reaches peak brain
concentrations 20 minutes after administration with significant levels of the drug observed
in the cortex, striatum, cerebellum, and hippocampus (Keller et al., 2002). Importantly,
previous research found that systemic administration of a 10 mg/kg dose of CP-154,526
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effectively reduced anxiety-like behavior in mice (Griebel et al., 1998). During operant
training (see below), mice received daily intraperitoneal (i.p.) injections of 0.5% CMC (5
ml/kg) 30-minutes before operant sessions to habituate them to injection procedures (except
in Experiment 4). Injection site was alternated between sides (left or right) daily to minimize
tissue damage.
Operant Training
Self-administration experiments were conducted in 16 modular mouse operant chambers
(Med Associates, Georgia, VT) with dimensions of 21.6 × 17.8 × 12.7 cm and a stainless
steel grid floor. All chambers were housed in a sound-attenuating shell with a ventilation
fan. Liquid receptacles were located in the center of the right and left chamber walls and a
stainless steel response lever was to the right of each receptacle. Liquid solutions (primary
lever produced sucrose or ethanol and a second lever produced water or was inactive) were
infused using 10 ml plastic syringes which were mounted on a programmable pump
(PHM-100, 3.33 rpm). The pump delivered 0.01 ml of solution per activation. A yellow
stimulus light and tone (80 dB) were activated when the primary lever (sucrose/ethanol
reinforced) was depressed (except in Experiment 3 below). No stimulus light or tone
occurred when the second lever (water reinforced or inactive) was pressed. A house light
inside the operant chambers was on for the duration of the test. Data recorded during each 2-
hour operant session included the number of sucrose/ethanol- and water-reinforced (or
inactive) responses (bar presses), the number of sucrose/ethanol and water reinforcers (pump
activation), and ethanol intake (g/kg body weight). The operant chambers were interfaced to
an IBM computer and all data were automatically recorded using Med Associates software
(MED-PC for Windows®, Version IV). All operant sessions were completed in the light
phase of the light/dark cycle.
Mice were placed under a modified operant sucrose fading procedure (Samson, 1986;
Schroeder et al., 2003). Briefly, mice were initially trained to respond to the levers.
Responses to the primary lever resulted in the delivery of a 10% sucrose solution (w/v) and
responses to the second lever caused delivery of distilled water (or was inactive). Mice were
allowed to respond for 10% sucrose for 4-days in 16-hour sessions in order to strengthen
lever pressing behavior. Sessions were then reduced to 2-hours per day for the remainder of
the experiment. Following stable responding (i.e., no significant differences in responding
over 3 consecutive days), increasing concentrations of ethanol were introduced to the 10%
sucrose solution every 2-days (2, 4, 8, and 10% ethanol (v/v)). Then, the sucrose
concentration was reduced every 2-days (5, 2, and 0% sucrose) until mice were responding
only for 10% ethanol. From the point at which ethanol was introduced into the sucrose
solution onward, mice were given access to two bottles in their homecages (one containing
water and the other contain an ethanol solution). The ethanol concentration presented in the
homecage matched the concentration of ethanol being tested in the operant chambers. Thus,
animals had access to ethanol for 24-hours per day during the ethanol training phase to
prevent ethanol deprivation. Once mice displayed stable responding for 10% ethanol
(approximately 2-weeks of training), ADE sessions were initiated. Lever responding over
the last 3-days of training were averaged for each mouse and served as their baseline
response rate.
Experiment 1: Effect of Ethanol Deprivation-Induced Lever Responding with Water
Reinforced Alternate Response Lever
Immediately following baseline sessions, mice (n = 32) were not run in the operant
chambers and homecage ethanol was removed for a 4-day ethanol deprivation period.
Following the deprivation period, mice were tested in daily 2-hour operant sessions over 3
consecutive days and given access to 10% ethanol in their homecages immediately after the
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first post-deprivation operant session. Ethanol deprivation and access were repeated, and
mice were then used in Experiment 2.
Experiment 2: Effect of CP-154,526 Administration on Ethanol Deprivation-Induced Lever
Responding with Water Reinforced Alternate Response Lever
Following 4-days of baseline responding, mice were deprived of ethanol for 4-days (no
operant sessions and no homecage ethanol access). Mice were distributed to 3 groups
matched for baseline lever responding and given i.p. injection of 0, 10, or 20 mg/kg doses of
CP-154,526 30-minutes before the test session which immediately followed the 4-day
deprivation period. The effects of CP-154,526 on deprivation-induced ethanol reinforced
lever pressing was then assessed over the 2-hour operant test session. After a second 4-day
deprivation period, mice previously injected with the 0 and 10 mg/kg doses of CP-154,526
(with the exception of two mice that became sick) were injected with the other dose 30-
minutes before a second 2-hour ADE test session. Mice previously injected with the 20 mg/
kg dose were not tested a second time due to the apparent aversive effects induced by this
high dose of CP-154,526. At the end of the study, the sample size for the 0, 10, and 20 mg/
kg groups were n = 25, 27, and 10, respectively.
Experiment 3: Ethanol Deprivation-Induced Lever Responding with Inactive Alternate
Response Lever
To further characterize the ADE using operant procedures, male C57BL/6J mice (n = 14)
were trained as described above with two exceptions: the second lever was inactive such that
responses were not reinforced, and no tone or light were presented when the primary lever
was activated. Following baseline responding, mice were deprived of ethanol for 4-days (no
operant procedures and no home cage ethanol access). Mice were then tested in 2-hour
operant sessions over 3 consecutive days along with homecage access to ethanol.
Experiment 4: Effect of CP-154,526 Administration on Sucrose Deprivation Testing with
Water Reinforced Alternate Response Lever
Male C57BL/6J mice (n = 15) were tested to determine if a 4-day deprivation and
pretreatment with CP-154,526 would alter lever pressing reinforced with 1% (w/v mixed in
tap water) sucrose. The 1% sucrose solution was chosen because it promoted similar levels
of lever pressing obtained with 10% ethanol reinforcement during 2-h test sessions.
Responding to the primary lever was reinforced with 1% sucrose and the second lever was
reinforced with water. During training, mice were also given 1% sucrose in addition to water
in their home cages. After a stable baseline for sucrose responding was established, mice
were distributed into two groups matched for baseline sucrose responding. Following a 4-
day sucrose deprivation period (no operant procedures and no home cage sucrose access),
mice were injected with 0 (n = 7) or a 10 mg/kg dose of CP-154,526 (n = 8) 30-minutes
before a 2-h operant test session.
Experiment 5: Ethanol Deprivation-Induced Lever Responding with Water Reinforced
Alternate Response Lever in Mice not given i.p. Injections
To determine if the stress associated with daily i.p. injections in Experiment 1-4 may have
altered the overall level of lever pressing, mice were tested in the operant self-administration
paradigm in the absence of i.p. injections. Briefly, male C57BL/6J mice (n = 32) were
trained to press levers for ethanol or water reinforcement as described above except i.p.
injections were never administered. Once stable responding occurred for the 10% ethanol
solution, mice were not run in the operant chambers and homecage ethanol was removed for
a 4-day break. Mice were then tested in 2-hour operant sessions over 3 consecutive days
with access to 10% ethanol in their homecages as described above.
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All data in this report are presented as means ± SEM. We used analyses of variance
(ANOVA) to analyze data from each experiment. When significant effects were obtained,
we performed planned comparisons with paired or independent t-tests (Winer et al., 1991).
Significance was accepted at p < 0.05 (two-tailed).
RESULTS
Experiment 1: Effect of Ethanol Deprivation-Induced Lever Responding with Water
Reinforced Alternate Response Lever
Fig. 1a depicts the mean lever responses for 10% ethanol (2-hour session) performed by
C57BL/6J mice at baseline (BL; last three sessions before the first ethanol deprivation cycle)
and during the three sessions of post-deprivation responding following the first and a
repeated deprivation session. A two-way mixed-factor ANOVA run on 10% ethanol lever
response data indicated a significant main effect of session [F(3,186) = 22.42, p < 0.01] and
a significant session × deprivation cycle interaction [F(3,186) = 3.80, p = 0.01]. Following
the 1st ethanol deprivation cycle, planned comparisons revealed that mice performed
significantly more responses for 10% ethanol on the first post-deprivation session relative to
baseline ethanol lever responding [t = 3.49, p < 0.01]. Following the repeated ethanol
deprivation cycle, the rate of ethanol lever pressing on the first, second, and third post-
deprivation sessions were significantly higher when compared to the baseline ethanol lever
responding [t = 6.68, p < 0.01; t = 4.24, p < 0.01; t = 3.17, p = 0.03, respectively]. Mean
lever responses for water at baseline and during the 2-hour post-deprivation sessions are
shown in Fig. 1b. A two-way mixed-factor ANOVA run on water data indicated a
significant main effect of session [F(3,186) = 16.95, p < 0.01] and a significant session ×
deprivation cycle interaction [F(3,186) = 5.24, p < 0.01]. Following the 1st ethanol
deprivation cycle, planned comparisons revealed that water lever pressing on the first
session of operant testing was significantly higher than the baseline water response rate [t =
4.67, p < 0.01]. Following the repeated ethanol deprivation cycle, lever pressing for water on
the first, second, and third post-deprivation sessions were significantly higher when
compared to the baseline water lever responding [t = 4.96, p < 0.01; t = 2.98, p = 0.01; t =
2.82, p = 0.01, respectively].
Figs. 1c and d present the amount of ethanol (g/kg) and water (ml/kg) consumed by mice,
respectively. A two-way mixed-factor ANOVA run on ethanol consumption data revealed a
significant main effect of session [F(3,186) = 21.11, p < 0.01] and a significant session ×
deprivation cycle interaction [F(3,186) = 3.38, p = 0.02]. Following the 1st ethanol
deprivation cycle, mice consumed significantly more ethanol relative to baseline following
the first post-deprivation session [t = 3.39, p < 0.01]. Following the repeated ethanol
deprivation cycle, mice consumed more ethanol relative to baseline during each of the three
post-deprivation sessions [t = 6.34, p < 0.01; t = 4.07, p < 0.01; t = 2.90, p < 0.01].
Similarly, a two-way mixed-factor ANOVA run on water consumption data revealed a
significant main effect of session [F(3,186) = 16.81, p < 0.01] and a significant session ×
deprivation cycle interaction [F(3,186) = 4.81, p < 0.01]. Following the first deprivation
cycle, mice showed elevated water consumption relative to baseline during the first post-
deprivation session [t = 4.66, p < 0.01], and following the repeated deprivation cycle water
consumption was significantly elevated above baseline levels during each of the three
sessions [t = 4.48, p < 0.01; t = 2.76, p = 0.01; t = 2.55, p = 0.02].
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Experiment 2: Effect of CP-154,526 Administration on Ethanol Deprivation-Induced Lever
Responding with Water Reinforced Alternate Response Lever
To determine if CRF-1 receptor signaling modulates deprivation-induced increases of
ethanol-reinforced lever pressing, mice were pretreated with the CRF-1 receptor antagonist
CP-154,526 30-minutes before testing. Fig. 2a depicts the mean lever responses for 10%
ethanol (2-hour session) performed by C57BL/6J mice during baseline and on the post-
deprivation session in which mice were administered CP-154,526 (0, 10, 20 mg/kg) 30-
minutes before operant testing. A one-way ANOVA comparing each of the four conditions
was significant [F(3,90) = 6.044, p = 0.001]. Consistent with the ADE, mice showed
significantly greater post-deprivation lever responding following administration of the
vehicle when compared to their baseline ethanol lever response rate [t = 2.07, p = 0.044].
Importantly, there was no significant difference between baseline ethanol responding and
post-deprivation ethanol responding when mice were administered the 10 mg/kg dose of
CP-154,526. However, the 20 mg/kg dose of CP-154,526 significantly reduced 10% ethanol
lever responding relative to baseline [t = 2.458, p = 0.018]. Fig. 2b depicts the mean lever
responses for water during baseline and on the post-deprivation session following
administration of CP-154,526 (0, 10, 20 mg/kg). A one-way ANOVA run on the data was
significant [F(3,90) = 4.94, p = 0.003]. The vehicle treated group had a significantly greater
number of water lever responses when compared to the baseline water lever response rate [t
= 2.18, p = 0.034]. Relative to baseline, there was no significant difference in water
responding following treatment with the 10 mg/kg dose of CP-154,526, and the 20 mg/kg
dose of CP-154,526 significantly reduced water lever responding relative to baseline [t =
3.424, p = 0.001].
Fig. 2c depicts the mean consumption of 10% ethanol (g/kg/2-hour session) by C57BL/6J. A
one-way ANOVA comparing each of the four conditions was significant [F(3,90) = 4.903, p
< 0.003]. Planned comparisons with two-tailed t-tests revealed that groups treated with
vehicle or the 10 mg/kg dose of CP-154,526 did not significantly differ in post-deprivation
ethanol consumption relative to baseline intake. Since we predicted a significant increase of
ethanol consumption following ethanol deprivation, we performed a directional one-tailed t-
test and found that the vehicle treated group showed a significant deprivation-induced
increase of ethanol consumption relative to baseline levels [t = 1.719, p = 0.0456]. The 20
mg/kg dose of CP-154,526 significantly reduced 10% ethanol intake relative to baseline [t =
2.458, p = 0.018]. Fig. 2d depicts water consumption (ml/kg/2-hour session) by the
C57BL6J mice. A one-way ANOVA run on the data was significant [F(3,90) = 4.903 p =
0.003]. The only significant planned comparison showed that the 20 mg/kg dose of
CP-154,526 significantly reduced water consumption relative to baseline [t = 3.503, p =
0.001].
Experiment 3: Ethanol Deprivation-Induced Lever Responding with Inactive Alternate
Response Lever
Unexpectedly, there was a deprivation-induced increase of water-reinforced lever
responding in Experiments 1 and 2. To determine if increased responding on the water-
reinforced lever may have resulted from a general non-specific increase in activity following
the deprivation sessions, Experiment 3 examined the ADE using operant procedures but
with the secondary lever inactive (non-reinforced). We reasoned that non-specific increases
of activity resulting from a deprivation period should also promote increased responding to a
non-reinforced lever. Fig. 3a depicts the mean lever responses for 10% ethanol (2-hour
session) performed by C57BL/6J mice at baseline (last three sessions before the first ethanol
deprivation cycle) and the three sessions of post-deprivation responding following the 4-day
deprivation. A repeated measures ANOVA comparing baseline responding and the 3-days of
post-deprivation responding was significant [F(3,39) = 3.671, p = 0.020]. Planned
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comparisons revealed that mice performed significantly more responses for 10% ethanol on
the first and second (but not third) post-deprivation session relative to baseline ethanol lever
responding [t = 2.434, p = 0.030; t = −2.902, p = 0.012]. Fig. 3b shows mean ethanol
consumption (g/kg/2-h) during this study. A repeated measures ANOVA comparing baseline
ethanol intake and the 3-days of post-deprivation ethanol consumption was significant
[F(3,39) = 3.920, p = 0.015], and planned comparisons revealed that mice consumed
significantly more 10% ethanol on the first and second (but not third) post-deprivation
session relative to baseline ethanol intake [t = 2.481, p = 0.028; t = 3.009, p = 0.010]. Fig. 3c
shows mean responses to the inactive lever during each 2-hour session. A repeated measures
ANOVA performed on these data did not achieve statistical significance [F(3,39) = 1.145, p
= 0.343].
Experiment 4: Effect of CP-154,526 Administration on Sucrose Deprivation Testing with
Water Reinforced Alternate Response Lever
To determine if the ability of CP-154,526 to attenuate deprivation-induced lever responding
was specific to ethanol reinforcement, we determined if the 10 mg/kg dose of this CRF-1
receptor antagonist would attenuate lever responding reinforced with 1% sucrose solution
following a 4-day deprivation period. Fig. 4a shows mean sucrose reinforced lever pressing
(over 2-hours) during baseline and on the session immediately after the 4-day sucrose
deprivation period, while Fig. 4b shows mean water reinforced responding on the second
lever during the same sessions. Two-way mixed factor ANOVAs performed on ethanol- and
water-reinforced lever responding data failed to show significant main effects of session
(baseline versus post-deprivation) or CP-154,526 dose (0 or 10 mg/kg) or significant
interaction effects. Figs. 4c and 4d show mean sucrose and water consumption during the
test, respectively. Similar to lever responding data, two-way mixed factor ANOVAs
performed on consumption data failed to achieve statistical significance.
Experiment 5: Ethanol Deprivation-Induced Lever Responding with Water Reinforced
Alternate Response Lever in Mice not given i.p. Injections
While we observed a deprivation-induced increase of ethanol self-administration in
Experiment 1, the amount of ethanol consumed after repeated deprivations was only about
1.0 g/kg over the 2-hour test. Since mice were periodically given i.p. injections in the
experiments above, the present experiment determined if the level of ethanol-reinforced
responding and ethanol intake would be higher in mice that did not experience injections
during the study. Fig. 5a depicts the mean lever responses for 10% ethanol (2-hour session)
performed by C57BL/6J mice at baseline (last three sessions before the first ethanol
deprivation cycle) and the three sessions of post-deprivation responding following the 4-day
deprivation period. A one-way repeated measures ANOVA performed on 10% ethanol lever
responding data was significant [F(3,93) = 8.786, p < 0.001]. Planned comparisons revealed
that mice performed significantly more responses for 10% ethanol on the first post-
deprivation session relative to baseline ethanol lever responding [t = 4.449, p < 0.001].
Mean lever responses for water at baseline and during the 2-hour post-deprivation sessions
are shown in Fig. 5b. A one-way repeated measures ANOVA performed on water lever
responding data was significant [F(3,93) = 6.460, p = 0.001] Water lever pressing on the
first post-deprivation session of operant testing was significantly higher than the baseline
water response rate [t = 3.595, p = 0.001].
Figs. 5c and d present the amount of ethanol (g/kg) and water (ml/kg) consumed by mice,
respectively. A repeated measures ANOVA performed on ethanol consumption data was
significant [F(3,93) = 8.736, p < 0.001], and planned comparisons showed that mice
consumed significantly more ethanol relative to baseline following the first post-deprivation
session [t = 4.065 p < 0.001]. Here, mice consumed approximately 2.0 g/kg of ethanol
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during the first 2-hour post-deprivation test session. Similarly, a repeated measures one-way
ANOVA performed on water consumption data revealed a significant effect [F(3,93) =
5.975, p = 0.001] and a planned comparison showed elevated water consumption relative to
baseline during the first post-deprivation session [t = 3.344, p = 0.002].
DISCUSSION
The present investigation shows that the ADE can be achieved with C57BL/6J mice using
operant self-administration procedures. These observations add to the literature by showing
that the ADE is associated with increased appetitive ethanol-seeking behavior (i.e., lever
pressing to gain access to ethanol reinforcement) as well as increased consummatory
behavior (ethanol consumption) when ethanol is returned after a period of forced abstinence
in C57BL/6J mice. These findings are consistent with the rat literature in which the ADE
has been observed using both bottle drinking and operant self-administration procedures
(e.g., (Overstreet et al., 2007; Rodd-Henricks et al., 2001; Rodd-Henricks et al., 2000a;
Rodd et al., 2003; Toalston et al., 2008)). Secondly, we show that pretreatment with a
CRF-1 receptor antagonist protects against deprivation-induced increases of ethanol self-
administration, an outcome evidenced by the observation the mice pre-treated with the 10
mg/kg dose of CP-154,526 showed levels of ethanol-reinforced lever pressing after 4-days
of ethanol deprivation that were similar to baseline levels (Experiment 2). These results
suggest that CRF-1 receptor signaling modulates the ADE in C57BL/6J mice.
One surprising observation in the present set of experiments was that the deprivation
procedure caused an increase of water-reinforced lever pressing that paralleled ethanol-
reinforced responding. This observation may suggest that the deprivation procedure
employed here promoted a general increase in activity when mice were returned to the
operant chambers, or that the deprivation procedure non-specifically enhanced the
reinforcing value of both ethanol and water. Both of these possibilities are unlikely for two
reasons. First, when the second operant lever was inactive (non-reinforced) in Experiment 3,
mice displayed deprivation-induced increases of ethanol-reinforced lever responding but no
significant increase of responding to the inactive key. If the deprivation procedure caused a
general increase of activity when mice were returned to the operant chambers, inactive lever
pressing would be expected to significantly increase, which did not happen (although there
was a modest non-significant elevation on post-deprivation days 1 and 2). Second, the
deprivation procedure did not lead to increased sucrose-reinforced lever pressing, a finding
indicating that deprivation does not promote a non-specific enhancement of reinforcer value.
The sucrose study also provides additional evidence against deprivation-induced increases
of general activity. One likely explanation for deprivation-induced increases of water-
reinforced responding is that since ethanol is a diuretic agent, the increased motivation to
gain access to water in mice with elevated ethanol self-administration may be due to thirst
resulting from dehydration. Consistent with this argument, deprivation-induced increase of
water-reinforced responding only occurred when ethanol served as the reinforcer for the
primary lever (Fig. 1, Fig. 2, and Fig. 5), but not when sucrose was used as the reinforcer on
the primary lever (Fig. 4).
In addition to demonstrating that the present ADE procedures do not promote deprivation-
induced increases of sucrose-reinforced behavior, the sucrose control study (Experiment 4)
also demonstrates that the effects of the 10 mg/kg dose of CP-154,526 were specific to
responding for ethanol. Thus, after a 4-day deprivation, mice pre-treated with the 10 mg/kg
dose of CP-154,526 showed levels of ethanol-reinforced responding that were similar to pre-
deprivation levels, while vehicle treated mice demonstrated the characteristic ADE. On the
other hand, the 10 mg/kg dose did not significantly alter sucrose-reinforced responding after
a 4- day deprivation period. Furthermore, we have previously shown that the 10 mg/kg dose
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of CP-154,526 does not alter open-field locomotor activity in C57BL/6J mice over a 4-hour
test (Sparta et al., 2008). These observations provide novel evidence suggesting that CRF-1
receptor signaling selectively modulates deprivation-induced increases of ethanol-seeking
behavior rather than affecting ongoing behavior in general. However, since mice had
experienced the ADE prior to the test with the CRF-1 receptor antagonist (in Experiment 1),
it is unclear if CRF-1 receptor blockade would attenuate the ADE after an initial ethanol
deprivation. It should be noted that the 20 mg/kg dose of CP-154,526 likely produced non-
specific behavioral side-effects as this dose reduced ethanol-reinforced responding below
levels observed in vehicle treated mice and below pre-deprivation baseline levels.
With the present procedures, activation of the primary lever caused a brief activation of light
and tone conditioned stimuli (CSs) that occurred concurrently with reinforcer presentation.
One potential concern is that these CSs may have acquired conditioned secondary reinforcer
value, and thus deprivation-induced increases of lever pressing may have been driven by CS
reinforcement rather than increased motivation to gain access to ethanol. There are two
observations that argue against this possibility. First, no light/tone CSs were used in
Experiment 3, yet deprivation-induced increases of ethanol-reinforced lever pressing were
observed. On the other hand, the CSs were used in the sucrose control study (Experiment 4)
where there were no observed increases of sucrose-reinforced lever pressing following
deprivation. Thus, a role for the CSs in modulating deprivation-induced increases of
ethanol-reinforced lever pressing seems unlikely.
In Experiment 1, mice consumed a little more than 1 g/kg/2-hours during the first day of
post-deprivation testing after repeated deprivation. To determine if the regular i.p. injections
given to mice may have led to an overall reduction of ethanol-seeking behavior and
consumption, mice were tested using the ADE procedures but without any i.p. injections in
Experiment 5. Consistent with an inhibitory effect of injections on ethanol-reinforced
responding, mice in Experiment 5 consumed approximately 2 g/kg/2-hours of ethanol during
the first test after the 4-day deprivation period. Based on previous research in which C57BL/
6J mice consumed approximately 2 g/kg of ethanol over a 2-hour test (Rhodes et al., 2005),
mice in Experiment 5 would have achieved blood ethanol levels of approximately 55 mg/ml
following the first day of post-deprivation testing, although caution is necessary with respect
to this blood ethanol estimate given the procedural differences between the Rhodes et al.
work and the present study. Nonetheless, based on the previous bottle drinking studies
(Rhodes et al., 2005), we speculate that longer test sessions (e.g., 4-hours) and testing within
the animal’s dark cycle would further increase deprivation-induced increases of ethanol-
reinforced responding.
While procedures involving bottle drinking allow for the analysis of factors that modulate
consummatory behavior, it has been suggested that operant procedures allow for the analysis
of appetitive or “ethanol-seeking” behavior (measured by lever pressing) as well as
consummatory behavior (Samson and Hodge, 1995). Previous work with mice using bottle
drinking procedures demonstrate that deprivation-induced increases of ethanol intake results
from increased levels of consummatory behavior (Cowen et al., 2003a; Cowen et al., 2003b;
Khisti et al., 2006; Melendez et al., 2006; Sanchis-Segura et al., 2006; Zghoul et al., 2007).
Using operant self-administration procedures, here we show that the ADE also involves
increased appetitive “ethanol-seeking” behavior. Because different neuronal pathways
appear to modulate appetitive versus consummatory behaviors during ethanol self-
administration (Czachowski et al., 2001a; Czachowski et al., 2001b; Czachowski et al.,
2002; Ford et al., 2007), the combined use of bottle drinking and operant self-administration
procedures will allow for a more complete characterization of the neurobiological
mechanisms underlying the ADE. Here we show that CRF-1 receptor signaling modulates
appetitive components of the ADE. It will be interesting to determine if CRF-1 receptor
Sparta et al. Page 10













antagonists also modulate deprivation-induced increases of ethanol intake using bottle
drinking procedures.
The present findings are consistent with previous data that have revealed a role for CRF
receptor signaling in neurobiological responses to ethanol. First, increased levels of CRF are
observed in the amygdala during ethanol withdrawal (Merlo Pich et al., 1995) while the
anxiogenic effect of ethanol withdrawal is reversed by CRF receptor antagonists (Breese et
al., 2004; Knapp et al., 2004; Overstreet et al., 2004; Rassnick et al., 1993). Second,
antagonism of CRF receptors attenuates increased ethanol drinking in rodents made
dependent to ethanol by exposure to ethanol diet or ethanol vapor, but has no effect on
moderate levels of ethanol consumption in non-dependent rodents (Chu et al., 2007; Finn et
al., 2007; Funk and Koob, 2007; Funk et al., 2006; Funk et al., 2007; Gehlert et al., 2007;
Valdez et al., 2002). Recently, we found that pre-treatment with CP-154,526 prevents binge-
like ethanol drinking in C57BL/6J mice (Sparta et al., 2008). Third, stress-induced
reinstatement of operant ethanol self-administration (an animal model of ethanol relapse) is
blocked by administration of a CRF receptor antagonist and increased by central infusion of
CRF (Le et al., 2000; Liu and Weiss, 2002; Stewart, 2004). Taken together with the present
results, a picture emerges such that CRF receptor signaling appears to be part of a dynamic
mechanism that is involved with the development of ethanol dependence stemming from
repeated ethanol exposure and withdrawal, a mechanism illustrated by the recently proposed
allostasis and “kindling”/stress models of drug dependence (Breese et al., 2005; Koob, 2003;
Koob and Le Moal, 2001).
In conclusion, we show here that the ADE in male C57BL/6J mice is observed using operant
self-administration procedures. Importantly, we provide novel evidence that expression of
the ADE in C57BL/6J mice may be modulated by the CRF-1 receptor. It will be important
to determine if the CRF-1 receptor modulates the ADE using bottle drinking procedures, or
if CRF-1 receptor signaling selectively modulates appetitive ethanol-seeking behaviors
associated with the ADE as revealed in the present study. The present work adds to a
growing body of literature implicating the CRF system in modulating neurobiological
responses to ethanol, observations that together suggesting a possible therapeutic role for
CRF-1 receptor antagonists in the treatment of alcoholism and the prevention of relapse.
Acknowledgments
This work was supported by NIH grants AA013573, AA015148, AA015875, AA015878, and the Department of
Defense grant W81XWH-06-1-0158. We thank Pfizer Inc. for their generous donation of CP-154,526. We thank
Lorraine Ko for her expert assistance with operant self-administration procedures.
REFERENCES
Backstrom P, Bachteler D, Koch S, Hyytia P, Spanagel R. mGluR5 antagonist MPEP reduces ethanol-
seeking and relapse behavior. Neuropsychopharmacology. 2004a; 29:921–928. [PubMed:
14735132]
Backstrom P, Bachteler D, Koch S, Hyytia P, Spanagel R. mGluR5 antagonist MPEP reduces ethanol-
seeking and relapse behavior. Neuropsychopharmacology. 2004b; 29:921–928. [PubMed:
14735132]
Barrick C, Connors GJ. Relapse prevention and maintaining abstinence in older adults with alcohol-
use disorders. Drugs Aging. 2002; 19:583–594. [PubMed: 12207552]
Bell RL, Rodd ZA, Boutwell CL, Hsu CC, Lumeng L, Murphy JM, Li TK, McBride WJ. Effects of
long-term episodic access to ethanol on the expression of an alcohol deprivation effect in low
alcohol-consuming rats. Alcohol Clin Exp Res. 2004; 28:1867–1874. [PubMed: 15608603]
Sparta et al. Page 11













Breese GR, Knapp DJ, Overstreet DH. Stress sensitization of ethanol withdrawal-induced reduction in
social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-
receptor agonist. Neuropsychopharmacology. 2004; 29:470–482. [PubMed: 12955093]
Breese GR, Overstreet DH, Knapp DJ. Conceptual framework for the etiology of alcoholism: a
"kindling"/stress hypothesis. Psychopharmacology. 2005; 178:367–380. [PubMed: 15765253]
Burish TG, Maisto SA, Cooper AM, Sobell MB. Effects of voluntary short-term abstinence from
alcohol on subsequent drinking patterns of college students. J Stud Alcohol. 1981; 42:1013–1020.
[PubMed: 7334801]
Chiauzzi, EJ. Preventing releapse in the addictions: a biopsychosocial approach. Pergamon Press;
1991. Pergamon Press.
Chu K, Koob GF, Cole M, Zorrilla EP, Roberts AJ. Dependence-induced increases in ethanol self-
administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1
receptor knockout. Pharmacol Biochem Behav. 2007; 86:813–821. [PubMed: 17482248]
Colombo G, Serra S, Brunetti G, Vacca G, Carai MA, Gessa GL. Suppression by baclofen of alcohol
deprivation effect in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend. 2003; 70:105–
108. [PubMed: 12681531]
Council, NR. Guide for the Care and Use of Laboratory Animals. National Academy Press; 1996.
National Academy Press.
Cowen MS, Schroff KC, Gass P, Sprengel R, Spanagel R. Neurobehavioral effects of alcohol in
AMPA receptor subunit (GluR1) deficient mice. Neuropharmacology. 2003a; 45:325–333.
[PubMed: 12871650]
Cowen MS, Schumann G, Yagi T, Spanagel R. Role of Fyn tyrosine kinase in ethanol consumption by
mice. Alcohol Clin Exp Res. 2003b; 27:1213–1219. [PubMed: 12966312]
Czachowski CL, Chappell AM, Samson HH. Effects of raclopride in the nucleus accumbens on
ethanol seeking and consumption. Alcohol Clin Exp Res. 2001a; 25:1431–1440. [PubMed:
11696662]
Czachowski CL, Legg BH, Samson HH. Effects of acamprosate on ethanol-seeking and self-
administration in the rat. Alcohol Clin Exp Res. 2001b; 25:344–350. [PubMed: 11290844]
Czachowski CL, Santini LA, Legg BH, Samson HH. Separate measures of ethanol seeking and
drinking in the rat: effects of remoxipride. Alcohol. 2002; 28:39–46. [PubMed: 12377359]
Dayas CV, Martin-Fardon R, Thorsell A, Weiss F. Chronic footshock, but not a physiological stressor,
suppresses the alcohol deprivation effect in dependent rats. Alcohol Alcohol. 2004; 39:190–196.
[PubMed: 15082455]
Finn DA, Snelling C, Fretwell AM, Tanchuck MA, Underwood L, Cole M, Crabbe JC, Roberts AJ.
Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF
receptor antagonist D-Phe-CRF(12–41). Alcohol Clin Exp Res. 2007; 31:939–949. [PubMed:
17403068]
Ford MM, Mark GP, Nickel JD, Phillips TJ, Finn DA. Allopregnanolone influences the consummatory
processes that govern ethanol drinking in C57BL/6J mice. Behav Brain Res. 2007; 179:265–272.
[PubMed: 17376546]
Fullgrabe MW, Vengeliene V, Spanagel R. Influence of age at drinking onset on the alcohol
deprivation effect and stress-induced drinking in female rats. Pharmacol Biochem Behav. 2007;
86:320–326. [PubMed: 17098280]
Funk CK, Koob GF. A CRF(2) agonist administered into the central nucleus of the amygdala
decreases ethanol self-administration in ethanol-dependent rats. Brain Res. 2007; 1155:172–178.
[PubMed: 17512918]
Funk CK, O'Dell LE, Crawford EF, Koob GF. Corticotropin-releasing factor within the central nucleus
of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent
rats. J Neurosci. 2006; 26:11324–11332. [PubMed: 17079660]
Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF. Corticotropin-releasing factor 1 antagonists
selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry. 2007;
61:78–86. [PubMed: 16876134]
Sparta et al. Page 12













Funk D, Vohra S, Le AD. Influence of stressors on the rewarding effects of alcohol in Wistar rats:
studies with alcohol deprivation and place conditioning. Psychopharmacology (Berl). 2004;
176:82–87. [PubMed: 15064919]
Gehlert DR, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C, Lu J, Hembre EJ, Cramer J,
Song M, McKinzie D, Morin M, Ciccocioppo R, Heilig M. 3-(4-Chloro-2-morpholin-4-yl-
thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl- imidazo[1,2-b]pyridazine: a novel brain-penetrant,
orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models
of alcoholism. J Neurosci. 2007; 27:2718–2726. [PubMed: 17344409]
Griebel G, Perrault G, Sanger DJ. Characterization of the behavioral profile of the non-peptide CRF
receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and
buspirone. Psychopharmacology (Berl). 1998; 138:55–66. [PubMed: 9694527]
Heyser CJ, Schulteis G, Koob GF. Increased ethanol self-administration after a period of imposed
ethanol deprivation in rats trained in a limited access paradigm. Alcohol Clin Exp Res. 1997;
21:784–791. [PubMed: 9267526]
Holter SM, Henniger MS, Lipkowski AW, Spanagel R. Kappa-opioid receptors and relapse-like
drinking in long-term ethanol-experienced rats. Psychopharmacology (Berl). 2000; 153:93–102.
[PubMed: 11255932]
Holter SM, Spanagel R. Effects of opiate antagonist treatment on the alcohol deprivation effect in
long-term ethanol-experienced rats. Psychopharmacology. 1999; 145:360–369. [PubMed:
10460312]
Jellinek EM. The craving for alcohol. Q J Stud Alcohol. 1955; 16:35–38. [PubMed: 14372010]
Keller C, Bruelisauer A, Lemaire M, Enz A. Brain pharmacokinetics of a nonpeptidic corticotropin-
releasing factor receptor antagonist. Drug Metab Dispos. 2002; 30:173–176. [PubMed: 11792687]
Khisti RT, Wolstenholme J, Shelton KL, Miles MF. Characterization of the ethanol-deprivation effect
in substrains of C57BL/6 mice. Alcohol. 2006; 40:119–126. [PubMed: 17307648]
Knapp DJ, Overstreet DH, Moy SS, Breese GR. SB242084, flumazenil, and CRA1000 block ethanol
withdrawal-induced anxiety in rats. Alcohol. 2004; 32:101–111. [PubMed: 15163561]
Koob GF. Alcoholism: allostasis and beyond. Alcohol Clin Exp Res. 2003; 27:232–243. [PubMed:
12605072]
Koob GF, Heinrichs SC, Pich EM, Menzaghi F, Baldwin H, Miczek K, Britton KT. The role of
corticotropin-releasing factor in behavioural responses to stress. Ciba Foundation Symposium.
1993; 172:277–289. [PubMed: 8491090]
Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis.
Neuropsychopharmacology. 2001; 24:97–129. [PubMed: 11120394]
Kornet M, Goosen C, Ribbens LG, van Ree JM. Analysis of spontaneous alcohol drinking in rhesus
monkeys. Physiol Behav. 1990; 47:679–684. [PubMed: 2385638]
Le AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y. The role of corticotrophin-releasing
factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl).
2000; 150:317–324. [PubMed: 10923760]
Liu X, Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking:
exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing
factor and opioid mechanisms. J Neurosci. 2002; 22:7856–7861. [PubMed: 12223538]
Lundkvist J, Chai Z, Teheranian R, Hasanvan H, Bartfai T, Jenck F, Widmer U, Moreau JL. A non
peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-
like activity. Eur J Pharmacol. 1996; 309:195–200. [PubMed: 8874139]
Marlatt GA, George WH. Relapse prevention: introduction and overview of the model. British Journal
of Addiction. 1984; 79:261–273. [PubMed: 6595020]
McKinzie DL, Nowak KL, Yorger L, McBride WJ, Murphy JM, Lumeng L, Li TK. The alcohol
deprivation effect in the alcohol-preferring P rat under free-drinking and operant access
conditions. Alcohol Clin Exp Res. 1998; 22:1170–1176. [PubMed: 9726292]
Melendez RI, Middaugh LD, Kalivas PW. Development of an alcohol deprivation and escalation effect
in C57BL/6J mice. Alcohol Clin Exp Res. 2006; 30:2017–2025. [PubMed: 17117967]
Mello NK, Mendleson MD. Drinking patterns during work-contigent and noncontigent alcohol alcohol
acquistion. Psychosom Med. 1972; 34:139–164. [PubMed: 5017102]
Sparta et al. Page 13













Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F. Increase
of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of
awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J
Neurosci. 1995; 15:5439–5447. [PubMed: 7643193]
Oster SM, Toalston JE, Kuc KA, Pommer TJ, Murphy JM, Lumeng L, Bell RL, McBride WJ, Rodd
ZA. Effects of multiple alcohol deprivations on operant ethanol self-administration by high-
alcohol-drinking replicate rat lines. Alcohol. 2006; 38:155–164. [PubMed: 16905441]
Overstreet DH, Knapp DJ, Breese GR. Modulation of multiple ethanol withdrawal-induced anxiety-
like behavior by CRF and CRF1 receptors. Pharmacol Biochem Behav. 2004; 77:405–413.
[PubMed: 14751471]
Overstreet DH, Knapp DJ, Breese GR. Drug challenges reveal differences in mediation of stress
facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P
rats. Alcohol Clin Exp Res. 2007; 31:1473–1481. [PubMed: 17624999]
Rasmussen DD, Boldt BM, Bryant CA, Mitton DR, Larsen SA, Wilkinson CW. Chronic daily ethanol
and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol Clin
Exp Res. 2000; 24:1836–1849. [PubMed: 11141043]
Rassnick S, Heinrichs SC, Britton KT, Koob GF. Microinjection of a corticotropin-releasing factor
antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol
withdrawal. Brain Res. 1993; 605:25–32. [PubMed: 8467387]
Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC. Evaluation of a simple model of ethanol
drinking to intoxication in C57BL/6J mice. Physiol Behav. 2005; 84:53–63. [PubMed: 15642607]
Rivier C, Bruhn T, Vale W. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role
of corticotropin-releasing factor (CRF). J Pharmacol Exp Ther. 1984; 229:127–131. [PubMed:
6323684]
Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, Li TK. Effects of
concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake
of alcohol-preferring rats. Alcohol Clin Exp Res. 2001; 25:1140–1150. [PubMed: 11505045]
Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, Li TK. Effects of
ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and
expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: I. Periadolescent
exposure. Alcohol Clin Exp Res. 2002a; 26:1632–1641. [PubMed: 12436051]
Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, Li TK. Effects of
ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and
expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: II. Adult exposure.
Alcohol Clin Exp Res. 2002b; 26:1642–1652. [PubMed: 12436052]
Rodd-Henricks ZA, McKinzie DL, Murphy JM, McBride WJ, Lumeng L, Li TK. The expression of an
alcohol deprivation effect in the high-alcohol-drinking replicate rat lines is dependent on repeated
deprivations. Alcoholism Clinical & Experimental Research. 2000a; 24:747–753.
Rodd-Henricks ZA, McKinzie DL, Shaikh SR, Murphy JM, McBride WJ, Lumeng L, Li TK. Alcohol
deprivation effect is prolonged in the alcohol preferring (P) rat after repeated deprivations. Alcohol
Clin Exp Res. 2000b; 24:8–16. [PubMed: 10656186]
Rodd ZA, Bell RL, Kuc KA, Murphy JM, Lumeng L, Li TK, McBride WJ. Effects of repeated alcohol
deprivations on operant ethanol self-administration by alcohol-preferring (P) rats.
Neuropsychopharmacology. 2003; 28:1614–1621. [PubMed: 12799615]
Rodd ZA, McKinzie DL, Bell RL, McQueen VK, Murphy JM, Schoepp DD, McBride WJ. The
metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol
self-administration in alcohol-preferring (P) rats. Behav Brain Res. 2006; 171:207–215. [PubMed:
16678921]
Samson HH. Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and
water-sated rats. Alcohol Clin Exp Res. 1986; 10:436–442. [PubMed: 3530023]
Samson, HH.; Hodge, CW. Neurobehavioral regulation of ethanol intake. In: Deitrich, RA.; Erwin,
VG., editors. Pharmacological Effects of Ethanol in the Nervous System. Boca Raton, FL: CRC
Press; 1995. p. 203-226.
Sparta et al. Page 14













Sanchis-Segura C, Borchardt T, Vengeliene V, Zghoul T, Bachteler D, Gass P, Sprengel R, Spanagel
R. Involvement of the AMPA receptor GluR-C subunit in alcohol-seeking behavior and relapse. J
Neurosci. 2006; 26:1231–1238. [PubMed: 16436610]
Schroeder JP, Iller KA, Hodge CW. Neuropeptide-Y Y5 receptors modulate the onset and maintenance
of operant ethanol self-administration. Alcohol Clin Exp Res. 2003; 27:1912–1920. [PubMed:
14691378]
Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S,
Schmidt AW, Seeger T, Seymour P, Tingley FD 3rd, Winston EN, Chen YL, Heym J.
CP-154,526: a potent and selective nonpeptide antagonist of corticotrophin releasing factor
receptors. Proc Natl Acad Sci U S A. 1996; 93:10477–10482. [PubMed: 8816826]
Serra S, Brunetti G, Vacca G, Lobina C, Carai MA, Gessa GL, Colombo G. Stable preference for high
ethanol concentrations after ethanol deprivation in Sardinian alcohol-preferring (sP) rats. Alcohol.
2003; 29:101–108. [PubMed: 12782251]
Sinclair JD. The alcohol-deprivation effect in monkeys. Psychon Sci. 1971; 25:1–22.
Sinclair JD, Le AD, Kiianmaa K. The AA and ANA rat lines, selected for differences in voluntary
alcohol consumption. Experientia. 1989; 45:798–805. [PubMed: 2673834]
Sinclair JD, Walker S, Jordan W. Behavioral and physiological changes associated with various
durations of alcohol deprivation in rats. Q J Stud Alcohol. 1973; 34:744–757. [PubMed: 4795453]
Spanagel R, Holter SM. Long-term alcohol self-administration with repeated alcohol deprivation
phases: an animal model of alcoholism? Alcohol Alcohol. 1999; 34:231–243. [PubMed:
10344783]
Spanagel R, Holter SM, Allingham K, Landgraf R, Zieglgansberger W. Acamprosate and alcohol: I.
Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol. 1996; 305:39–
44. [PubMed: 8813529]
Sparta DR, Sparrow AM, Lowery EG, Fee JR, Knapp DJ, Thiele TE. Blockade of the corticotropin
releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the
dark procedures. Alcohol Clin Exp Res. 2008; 32:259–265. [PubMed: 18162072]
Stewart J. Pathways to relapse: factors controlling the reinitiation of drug seeking after abstinence.
Nebr Symp Motiv. 2004; 50:197–234. [PubMed: 15160642]
Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotrophin-releasing
factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.
Neuroendocrinology. 1983; 36:165–186. [PubMed: 6601247]
Toalston JE, Oster SM, Kuc KA, Pommer TJ, Murphy JM, Lumeng L, Bell RL, McBride WJ, Rodd
ZA. Effects of alcohol and saccharin deprivations on concurrent ethanol and saccharin operant
self-administration by alcohol-preferring (P) rats. Alcohol. 2008
Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, Koob GF. Increased ethanol self-
administration and anxiety-like behavior during acute ethanol withdrawal and protracted
abstinence: Regulation by corticotropin-releasing factor. Alcoholism: Clinical & Experimental
Research. 2002; 26:1494–1501.
Vengeliene V, Bachteler D, Danysz W, Spanagel R. The role of the NMDA receptor in alcohol
relapse: a pharmacological mapping study using the alcohol deprivation effect.
Neuropharmacology. 2005; 48:822–829. [PubMed: 15829254]
Vengeliene V, Leonardi-Essmann F, Perreau-Lenz S, Gebicke-Haerter P, Drescher K, Gross G,
Spanagel R. The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse.
Faseb J. 2006; 20:2223–2233. [PubMed: 17077299]
Winer, BJ.; Brown, DR.; Michels, KM. Statistical Principles in Experimental Design. Third edn.
McGraw-Hill, Inc.; 1991. McGraw-Hill, Inc.
Wolffgramm J, Heyne A. From controlled drug intake to loss of control: the irreversible development
of drug addiction in the rat. Behav Brain Res. 1995; 70:77–94. [PubMed: 8519431]
Zghoul T, Abarca C, Sanchis-Segura C, Albrecht U, Schumann G, Spanagel R. Ethanol self-
administration and reinstatement of ethanol-seeking behavior in Per1(Brdm1) mutant mice.
Psychopharmacology (Berl). 2007; 190:13–19. [PubMed: 17051414]
Sparta et al. Page 15














Lever responses for 10% (v/v) ethanol (a) and water (b) during the 2-hour test sessions
following the first 4-day ethanol deprivation cycle (deprivation 1) and after a repeated
ethanol deprivation cycle (repeated deprivation). Consumption of 10% (v/v) ethanol (g/kg)
(c) and water (ml/kg) (d) during the 2-hour test sessions following the first and repeated
ethanol deprivation cycles. Baseline (BL) refers to the average of the last three sessions
before ADE procedures were introduced. All values are means ± SEM. *p < 0.05 relative to
baseline measures.
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Lever responses for 10% (v/v) ethanol (a) and water (b), and consumption of ethanol (c) and
water (d) during the 2-hour test immediately following 4-days of ethanol deprivation. Mice
were given an intraperitoneal (i.p.) injection of the CRF-1 receptor antagonist CP-154,526
(0, 10, 20 mg/kg) 30-minutes before testing. Baseline (BL) refers to the average of the last
three sessions before ADE procedures were introduced. All values are means ± SEM. *p <
0.05 relative to baseline measures.
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Lever responses for 10% (v/v) ethanol (a) ethanol consumption (b), and responses on the
inactive lever (c) during the 2-hour test sessions following the 4-day ethanol deprivation
cycle. Baseline (BL) refers to the average of the last three sessions before ADE procedures
were introduced. All values are means ± SEM. p < 0.05 relative to baseline measures.
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Lever responses for 1% (w/v) sucrose (a) and water (b), and consumption of sucrose (c) and
water (d) during the 2-hour test session following the 4-day sucrose deprivation cycle.
Baseline (BL) refers to the average of the last three sessions before the 4-day deprivation
procedure. On the test day (Post-Deprivation) mice were given intraperitoneal (i.p.) injection
of the CRF-1 receptor antagonist CP-154,526 (0 or 10 mg/kg) 30-minutes before testing. All
values are means ± SEM.
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Lever responses for 10% (v/v) ethanol (a) and water (b), and consumption of ethanol (c) and
water (d) during the 2-hour test sessions following the 4-day ethanol deprivation cycle.
Baseline (BL) refers to the average of the last three sessions before ADE procedures were
introduced. All values are means ± SEM. p < 0.05 relative to baseline measures.
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